Neurobiological Technologies, Inc.
NTII
$0.00
$0.000.00%
OTC PK
| 12/17/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Net Income | -108.55% | -61.81% | 3,383.99% | 94.50% | -183.78% |
| Total Depreciation and Amortization | -142.86% | -30.00% | -13.04% | -42.50% | -18.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.27% | -114.06% | 168.64% | 0.25% | 991.89% |
| Change in Net Operating Assets | 204.78% | 85.70% | -501.86% | -238.11% | 828.57% |
| Cash from Operations | 2.84% | 146.31% | -50.33% | 31.58% | -64.21% |
| Capital Expenditure | -- | -- | -200.00% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -200.00% | 1,500.00% | -200.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,692.82% | -113.91% | 195.27% | 117.36% | -1,293.56% |
| Cash from Investing | 1,713.66% | -113.72% | 194.80% | 117.38% | -1,295.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -595.79% | -39.08% | 345.41% | 95.29% | -955.96% |